Literature DB >> 16512878

Interferon-gamma down-regulates expression of the 230-kDa bullous pemphigoid antigen gene (BPAG1) in epidermal keratinocytes via novel chimeric sequences of ISRE and GAS.

Takahide Kaneko1, Katsuto Tamai, Yasushi Matsuzaki, Takehiko Yamazaki, Hajime Nakano, Atsushi Kon, Isao Hashimoto, Katsumi Hanada, Yasuhumi Kaneda, Jouni Uitto.   

Abstract

The 230-kDa bullous pemphigoid antigen (BPAG1) is an integral component of hemidesmosomes. We have previously reported that interferon-gamma (IFNgamma) inhibits the transcription of the BPAG1 gene (1). Here we investigated the target sequences of IFNgamma-signal transduction pathway in the BPAG1 promoter in epidermal keratinocytes. Transient transfections with 5'-deletion constructs of BPAG1 promoter-luciferase reporter gene plasmids in cultured normal human epidermal keratinocytes (NHEK) allowed us to narrow the DNA region containing IFNgamma inhibitory element (IGIE) to between -1 and -89, upstream from the transcription initiation site (+1). Homology search in this region identified a chimeric sequence, consisting of IFN-stimulated responsive element (ISRE) with a partial 7-bp sequence of IFNgamma activation site (GAS), as identified in the guanylate-binding protein (GBP) gene, inserted at its center. Functional analysis of IGIE, inserted in front of the heterologous thymidine kinase promoter, indicated that IGIE acts as a down-regulatory element of the promoter through IFNgamma-dependent signal pathway. Transient transfection studies with BPAG1 promoter-reporter gene constructs containing mutated IGIE (with TT to GG transversions in the region of 5'ISRE, GAS, and 3'ISRE) demonstrated that disruption of the ISRE sequences, but not GAS, markedly suppressed the BPAG1 basal promoter activity and resulted in attenuated IFNgamma response in keratinocytes. Our findings provide novel insight into the mechanism of IFNgamma regulation in keratinocyte differentiation and proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16512878     DOI: 10.1111/j.0906-6705.2006.00408.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  6 in total

1.  The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and Angiogenesis.

Authors:  Katie M Leick; Anthony B Rodriguez; Marit M Melssen; Mouadh Benamar; Robin S Lindsay; Rebeka Eki; Kang-Ping Du; Mahmut Parlak; Tarek Abbas; Victor H Engelhard; Craig L Slingluff
Journal:  Ann Surg       Date:  2019-10       Impact factor: 12.969

2.  Molecular mechanisms for synchronized transcription of three complement C1q subunit genes in dendritic cells and macrophages.

Authors:  Guobao Chen; Carol Shurong Tan; Boon King Teh; Jinhua Lu
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

3.  MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes.

Authors:  Ai-Yu Gong; Rui Zhou; Guoku Hu; Xiaoqing Li; Patrick L Splinter; Steven P O'Hara; Nicholas F LaRusso; Garrett A Soukup; Haidong Dong; Xian-Ming Chen
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

4.  Susceptibility loci revealed for bovine respiratory disease complex in pre-weaned holstein calves.

Authors:  Holly L Neibergs; Christopher M Seabury; Andrzej J Wojtowicz; Zeping Wang; Erik Scraggs; Jennifer N Kiser; Mahesh Neupane; James E Womack; Alison Van Eenennaam; Gerald Robert Hagevoort; Terry W Lehenbauer; Sharif Aly; Jessica Davis; Jeremy F Taylor
Journal:  BMC Genomics       Date:  2014-12-22       Impact factor: 3.969

5.  Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.

Authors:  K Juczynska; A Wozniacka; E Waszczykowska; M Danilewicz; M Wagrowska-Danilewicz; J Wieczfinska; R Pawliczak; A Zebrowska
Journal:  Mediators Inflamm       Date:  2017-10-24       Impact factor: 4.711

6.  Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris.

Authors:  K Juczynska; A Wozniacka; E Waszczykowska; M Danilewicz; M Wągrowska-Danilewicz; Agnieszka Zebrowska
Journal:  Immunol Res       Date:  2020-04       Impact factor: 2.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.